|
|
Volumn 95, Issue 3, 2002, Pages 153-158
|
|
Management of hyperemesis gravidarum: The importance of weight loss as a criterion for steroid therapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETAMETHASONE;
CORTICOSTEROID;
CYCLIZINE;
HYDROCORTISONE;
METOCLOPRAMIDE;
PREDNISOLONE;
PROCHLORPERAZINE MALEATE;
THIAMINE;
ADULT;
ARTICLE;
BIRTH WEIGHT;
CLINICAL OBSERVATION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE SEVERITY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG WITHDRAWAL;
FEMALE;
GESTATION PERIOD;
HOSPITAL ADMISSION;
HOSPITAL DISCHARGE;
HUMAN;
HYPEREMESIS GRAVIDARUM;
MAJOR CLINICAL STUDY;
MEDICAL DOCUMENTATION;
MEDICAL INFORMATION;
NAUSEA AND VOMITING;
OSTEOPENIA;
PREGNANCY DIABETES MELLITUS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SYMPTOMATOLOGY;
WEIGHT GAIN;
WEIGHT REDUCTION;
|
|
EID: 0036121727
PISSN: 14602725
EISSN: None
Source Type: Journal
DOI: 10.1093/qjmed/95.3.153 Document Type: Article |
|
Times cited : (29)
|
|
References (21)
|
